Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Ando

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
Cellular Immunology|November 1, 1989
Encephalitogenic T cells in the B10.PL model of experimental allergic encephalomyelitis (EAE) are of the Th-1 lymphokine subtypeD G Ando, J Clayton, D Kono, et al.
The Journal of Rheumatology. Supplement|June 1, 1987
Idiotype regulatory networks promote autoantibody formationB H Hahn, D G Ando, K Dunn, et al.
Journal of Autoimmunity|February 1, 1988
Idiotypic spreading promotes the production of pathogenic autoantibodiesF M Ebling, D G Ando, N Panosian-Sahakian, et al.
The Journal of Experimental Medicine|July 1, 1988
Two minor determinants of myelin basic protein induce experimental allergic encephalomyelitis in SJL/J miceD H Kono, J L Urban, S J Horvath, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 15, 1992
Inflammatory leukocytes and cytokines in the peptide-induced disease of experimental allergic encephalomyelitis in SJL and B10.PL miceJ E Merrill, D H Kono, J Clayton, et al.
The Journal of Experimental Medicine|May 1, 1989
Peptide-specific prevention of experimental allergic encephalomyelitis. Neonatal tolerance induced to the dominant T cell determinant of myelin basic proteinJ P Clayton, G M Gammon, D G Ando, et al.
The American Journal of Medicine|November 1, 1988
Clinical significance of a single test for anti-cardiolipin antibodies in patients with systemic lupus erythematosusK C Kalunian, J B Peter, H R Middlekauff, et al.
Cell|August 12, 1988
Restricted use of T cell receptor V genes in murine autoimmune encephalomyelitis raises possibilities for antibody therapyJ L Urban, V Kumar, D H Kono, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2006
Phase I/II trial of an allogeneic cellular immunotherapy in hormone-naïve prostate cancerJonathan W Simons, Michael A Carducci, Bahar Mikhak, et al.
The New England Journal of Medicine|March 7, 2014
Gene editing of CCR5 in autologous CD4 T cells of persons infected with HIVPablo Tebas, David Stein, Winson W Tang, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Cellular Immunology|November 1, 1989
Encephalitogenic T cells in the B10.PL model of experimental allergic encephalomyelitis (EAE) are of the Th-1 lymphokine subtypeD G Ando, J Clayton, D Kono, et al.
The Journal of Rheumatology. Supplement|June 1, 1987
Idiotype regulatory networks promote autoantibody formationB H Hahn, D G Ando, K Dunn, et al.
Journal of Autoimmunity|February 1, 1988
Idiotypic spreading promotes the production of pathogenic autoantibodiesF M Ebling, D G Ando, N Panosian-Sahakian, et al.
The Journal of Experimental Medicine|July 1, 1988
Two minor determinants of myelin basic protein induce experimental allergic encephalomyelitis in SJL/J miceD H Kono, J L Urban, S J Horvath, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 15, 1992
Inflammatory leukocytes and cytokines in the peptide-induced disease of experimental allergic encephalomyelitis in SJL and B10.PL miceJ E Merrill, D H Kono, J Clayton, et al.
The Journal of Experimental Medicine|May 1, 1989
Peptide-specific prevention of experimental allergic encephalomyelitis. Neonatal tolerance induced to the dominant T cell determinant of myelin basic proteinJ P Clayton, G M Gammon, D G Ando, et al.
The American Journal of Medicine|November 1, 1988
Clinical significance of a single test for anti-cardiolipin antibodies in patients with systemic lupus erythematosusK C Kalunian, J B Peter, H R Middlekauff, et al.
Cell|August 12, 1988
Restricted use of T cell receptor V genes in murine autoimmune encephalomyelitis raises possibilities for antibody therapyJ L Urban, V Kumar, D H Kono, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2006
Phase I/II trial of an allogeneic cellular immunotherapy in hormone-naïve prostate cancerJonathan W Simons, Michael A Carducci, Bahar Mikhak, et al.
The New England Journal of Medicine|March 7, 2014
Gene editing of CCR5 in autologous CD4 T cells of persons infected with HIVPablo Tebas, David Stein, Winson W Tang, et al.
Pageof 4